Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...

Prostate cancer has overtaken breast cancer to become the most common form of the disease in the UK for the first time.

Prostate cancer has now taken over as the most commonly diagnosed cancer in the UK, pushing breast cancer into second place ...

Prostate cancer has now become the most prevalent cancer across the UK, new analysis reveals, surpassing breast cancer as the ...

Prostate cancer is now the most common cancer in the UK, according to a new analysis. Figures examined by the charity ...

Researchers found a sharp increase in the number of men being diagnosed with prostate cancer in just a year. The Daily Mail ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

A multitargeted T-cell therapy produced encouraging activity in a preliminary study of patients with pancreatic cancer, ...

It’s a problem with not nearly enough attention. Prostate cancer hits men hard all over the world—it’s one of the biggest ...

More than 70% of people diagnosed with cancer in the United States now survive for five years or more, a milestone experts ...

Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...